260 related articles for article (PubMed ID: 28873353)
21. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.
Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C
Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948
[TBL] [Abstract][Full Text] [Related]
22. Nasal-type extranodal natural killer/T-cell lymphoma presenting with extensive leg ulcers.
Chia HY; Tey HL; Tan KB; Chong WS
Clin Exp Dermatol; 2009 Dec; 34(8):e693-5. PubMed ID: 20055838
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous peripheral T-cell lymphoma of cytotoxic phenotype mimicking extranodal NK/T-cell lymphoma.
Pan ST; Chang WS; Murphy M; Martinez A; Chuang SS
Am J Dermatopathol; 2011 Apr; 33(2):e17-20. PubMed ID: 21252637
[TBL] [Abstract][Full Text] [Related]
24. Wait and see: a case of EBV + cutaneous extranodal NK/T-type lymphoma with indolent behaviour.
Aromolo IF; Pescia C; Simeoli D; Violetti SA; Ferla V; Rossi FG; Croci GA
Virchows Arch; 2024 Jun; 484(6):1029-1032. PubMed ID: 37870613
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous EBV-positive γδ T-cell lymphoma vs. extranodal NK/T-cell lymphoma: a case report and literature review.
Yu WW; Hsieh PP; Chuang SS
J Cutan Pathol; 2013 Mar; 40(3):310-6. PubMed ID: 23240992
[TBL] [Abstract][Full Text] [Related]
26. Genotypic analysis and latent membrane protein 1 expression of Epstein-Barr virus in extranodal NK/T-cell lymphoma from Northern Chinese patients.
Wang H; Li H; Xing X; Zhao C; Luo B
Arch Virol; 2015 Aug; 160(8):2071-4. PubMed ID: 26008210
[TBL] [Abstract][Full Text] [Related]
27. A case of primary cutaneous extranodal natural killer/t-cell lymphoma, nasal type, with a 22-year indolent clinical course.
Zuriel D; Fink-Puches R; Cerroni L
Am J Dermatopathol; 2012 Apr; 34(2):194-7. PubMed ID: 22172956
[TBL] [Abstract][Full Text] [Related]
28. Extranodal natural killer/T-cell lymphoma, nasal type: a Spanish multicentric retrospective survey.
Rozas-Muñoz E; Gallardo F; Pujol RM; Pérez-Ferriols A; Servitje O; Estrach T; Bastida J; Román C; Palacio-Aller L; Gil I; Martí RM; Vidal-Sarró D; García-Muret MP
Eur J Dermatol; 2018 Feb; 28(1):64-70. PubMed ID: 29400283
[TBL] [Abstract][Full Text] [Related]
29. Extranodal NK/T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups--a retrospective study of 18 patients.
Choi YL; Park JH; Namkung JH; Lee JH; Yang JM; Lee ES; Lee DY; Jang KT; Ko YH
Br J Dermatol; 2009 Feb; 160(2):333-7. PubMed ID: 19014396
[TBL] [Abstract][Full Text] [Related]
30. CD30-positive cutaneous extranodal natural killer/T-cell lymphoma: clinicopathological features and survival outcomes.
Lee WJ; Moon IJ; Shin HJ; Won CH; Chang SE; Choi JH; Lee MW
Int J Dermatol; 2019 Jun; 58(6):688-696. PubMed ID: 30597548
[TBL] [Abstract][Full Text] [Related]
31. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
Ko YH; Cho EY; Kim JE; Lee SS; Huh JR; Chang HK; Yang WI; Kim CW; Kim SW; Ree HJ
Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996
[TBL] [Abstract][Full Text] [Related]
32. Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis.
Kim WY; Jung HY; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
Virchows Arch; 2016 Nov; 469(5):581-590. PubMed ID: 27595782
[TBL] [Abstract][Full Text] [Related]
33. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous natural killer/T-cell lymphoma of the nasal type: a report of 4 cases in North American patients.
Peck T; Wick MR
Ann Diagn Pathol; 2015 Aug; 19(4):211-5. PubMed ID: 25952095
[TBL] [Abstract][Full Text] [Related]
35. [Extranodal nasal type NK/T-cell lymphoma: clinicopathologic and prognostic study of 55 cases].
Li L; Liu YH; Zhuang HG; Luo XL; Zhang F; Xu FP; Luo DL
Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):237-42. PubMed ID: 19575894
[TBL] [Abstract][Full Text] [Related]
36. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.
Jhuang JY; Chang ST; Weng SF; Pan ST; Chu PY; Hsieh PP; Wei CH; Chou SC; Koo CL; Chen CJ; Hsu JD; Chuang SS
Hum Pathol; 2015 Feb; 46(2):313-21. PubMed ID: 25554090
[TBL] [Abstract][Full Text] [Related]
37. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
[TBL] [Abstract][Full Text] [Related]
38. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.
Tababi S; Kharrat S; Sellami M; Mamy J; Zainine R; Beltaief N; Sahtout S; Besbes G
Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Jun; 129(3):141-7. PubMed ID: 22321911
[TBL] [Abstract][Full Text] [Related]
39. Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.
Vazquez A; Khan MN; Blake DM; Sanghvi S; Baredes S; Eloy JA
Laryngoscope; 2014 Apr; 124(4):888-95. PubMed ID: 24114591
[TBL] [Abstract][Full Text] [Related]
40. Extranodal natural killer cell/t-cell lymphoma, nasal type, presenting as cutaneous nodules and a small-bowel perforation.
Agarwal P; Ruzinova MB; Harris MH; Qureshi AA; Stebbins WG
Am J Dermatopathol; 2010 Feb; 32(1):83-5. PubMed ID: 19940752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]